Prescient Therapeutics Investor Briefing – 27 May
Prescient Therapeutics (ASX: PTX) Webcast Replay
Prescient Therapeutics (ASX:PTX) is focused on developing novel, personalised therapies against a range of cancers.
As a part of our ‘Meet the CEOs’ series, CEO Steven Yatomi-Clarke provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 27th May 2020 at 12pm (AEST).